Earnings History Data for Brainstorm Cell Therapeutics (BCLI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Brainstorm Cell Therapeutics
BrainStorm Cell Therapeutics Inc. is a biotechnology company. It develops autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Multiple Sclerosis and Parkinson's disease. Brainstorm Cell Therapeutics is based in New York.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | AH | BCLI | Brainstorm Cell Therapeutics | 6.00 | -1.80 | -0.45 | 0.00 | BrainStorm Cell Therapeutics GAAP EPS of -$1.80 [11/14/2024 5:03 PM] |
1.20 | 0.07 (6.18%) |
1.13 | 0.0 (0.00%) |
1.05 - 11.89 | 132,837 | 170,000 | 6,231 | ||
| 14-08-2024 | PM | BCLI | Brainstorm Cell Therapeutics Inc. | 18.15 | -0.04 | -0.04 | -0.13 | BrainStorm Cell Therapeutics GAAP EPS of -$0.04 in-line [8/14/2024 7:34 AM] |
0.3125 | -0.01 (-2.04%) |
0.31 | -0.01 (-3.76%) |
0.13 - 1.81 | 880,754 | 490,000 | 1,916,697 | ||
| 14-05-2024 | PM | BCLI | Brainstorm Cell Therapeutics | 31.00 | -0.05 | -0.07 | 0.00 | BrainStorm Cell Therapeutics GAAP EPS of -$0.05 beats by $0.02 [5/15/2024 9:45 AM] |
0.4858 | -0.01 (-2.86%) |
0.55 | 0.05 (9.78%) |
0.13 - 3.34 | 417,461 | 840,000 | 2,409 | ||
| 01-04-2024 | PM | BCLI | Brainstorm Cell Therapeutics | 28.00 | -0.11 | -0.15 | 0.00 | BrainStorm Cell Therapeutics GAAP EPS of -$0.40 beats by $0.16 [4/1/2024 8:44 AM] |
0.74 | 0.18 (31.04%) |
0.62 | 0.06 (9.78%) |
0.13 - 3.43 | 1,323,167 | 1,770,000 | 60,722 | ||
| 14-11-2023 | PM | BCLI | Brainstorm Cell Therapeutics Inc. | 7.67 | -0.14 | -0.14 | -0.19 | BrainStorm Cell Therapeutics GAAP EPS of -$0.29 misses by $0.15 [11/14/2023 7:07 AM] |
0.1890 | 0.0 (2.16%) |
0.18 | -0.01 (-3.14%) |
0.13 - 3.46 | 2,828,742 | 830,000 | 131,301 | ||
| 14-08-2023 | PM | BCLI | Brainstorm Cell Therapeutics Inc. | 63.84 | -0.27 | -0.15 | -0.19 | BrainStorm Cell Therapeutics GAAP EPS of -$0.27 misses by $0.13 [8/14/2023 7:44 AM] |
1.66 | 0.03 (2.16%) |
1.62 | 0.0 (0.00%) |
1.09 - 4.70 | 277,775 | 160,000 | 1,889 | ||
| 15-05-2023 | PM | 7:05 AM ET (May 15) |
BCLI | Brainstorm Cell Therapeutics Inc. | 104.89 | -0.14 | -0.16 | -0.15 | BrainStorm Cell Therapeutics GAAP EPS of -$0.14 beats by $0.03 [5/15/2023 7:13 AM] |
2.75 | -0.01 (-0.54%) |
2.83 | 0.07 (2.54%) |
1.09 - 4.70 | 211,474 | 200,000 | 5,329 | |
| 30-03-2023 | PM | 7:05 AM ET (Mar 30) |
BCLI | Brainstorm Cell Therapeutics Inc. | 80.76 | -0.14 | 0.00 | -0.17 | BrainStorm Cell Therapeutics GAAP EPS of -$0.66 misses by $0.52 [3/30/2023 7:06 AM] |
2.53 | 0.09 (3.69%) |
2.41 | -0.03 (-1.23%) |
1.09 - 4.70 | 647,804 | 630,000 | 17,864 | |
| 14-11-2022 | PM | 7:05 AM ET (Nov 14) |
BCLI | Brainstorm Cell Therapeutics Inc. | 60.93 | -0.19 | -0.15 | -0.15 | BrainStorm Cell Therapeutics GAAP EPS of -$0.53 [11/14/2022 7:08 AM] |
1.65 | 0.13 (8.55%) |
1.51 | -0.01 (-0.66%) |
1.09 - 4.70 | 617,855 | 360,000 | 70,150 | |
| 15-08-2022 | PM | 7:05 AM ET (Aug 15) |
BCLI | Brainstorm Cell Therapeutics | 108.00 | -0.19 | -0.15 | 0.00 | BrainStorm Cell Therapeutics GAAP EPS of -$0.34 [8/15/2022 7:07 AM] |
3.50 | 0.0 (0.00%) |
4.04 | 0.54 (15.43%) |
2.52 - 4.70 | 1,680,495 | 110,000 | 140,382 | |
| 16-05-2022 | PM | 7:05 AM ET (May 16) |
BCLI | Brainstorm Cell Therapeutics Inc. | 98.88 | -0.15 | -0.13 | -0.19 | BrainStorm Cell Therapeutics GAAP EPS of -$0.15 misses by $0.02 [5/16/2022 7:08 AM] |
2.84 | 0.12 (4.45%) |
0.0 | 0.0 (0.00%) |
2.65 - 4.46 | 75,478 | 120,000 | 0 | |
| 28-03-2022 | PM | 7:00 AM ET (Mar 28) |
BCLI | Brainstorm Cell Therapeutics Inc. | 125.88 | -0.17 | -0.20 | -0.37 | BrainStorm Cell Therapeutics GAAP EPS of -$0.68 beats by $0.11 [3/28/2022 7:08 AM] |
3.23 | -0.15 (-4.44%) |
0.0 | 0.0 (0.00%) |
2.75 - 4.46 | 82,951 | 60,000 | 0 | |
|
||||||||||||||||||
| 15-11-2021 | PM | 7:00 AM ET (Nov 15) |
BCLI | Brainstorm Cell Therapeutics | 108.00 | -0.15 | -0.21 | 0.00 | BrainStorm Cell Therapeutics EPS misses by $0.31 [11/15/2021 7:04 AM] |
3.06 | 0.09 (3.03%) |
2.97 | 0.0 (0.00%) |
2.81 - 12.30 | 213,139 | 110,000 | 286 | |
| 05-08-2021 | PM | 7:00 AM ET (Aug 5) |
BCLI | Brainstorm Cell Therapeutics Inc. | 148.54 | -0.17 | -0.20 | -0.25 | BrainStorm Cell Therapeutics EPS beats by $0.05 [8/5/2021 7:11 AM] |
3.94 | 0.17 (4.51%) |
3.80 | 0.03 (0.80%) |
2.92 - 17.95 | 234,298 | 230,000 | 519 | |
| 26-04-2021 | PM | 7:00 AM ET (Apr 26) |
BCLI | Brainstorm Cell Therapeutics Inc. | 117.88 | -0.19 | -0.27 | -0.32 | BrainStorm Cell Therapeutics EPS beats by $0.07 [4/26/2021 7:02 AM] |
3.58 | 0.12 (3.47%) |
3.53 | 0.07 (2.02%) |
2.97 - 17.95 | 641,442 | 480,000 | 18,305 | |
| 04-02-2021 | PM | BCLI | Brainstorm Cell Therapeutics Inc. | 185.00 | -0.37 | -0.48 | 0.00 | BrainStorm Cell Therapeutics EPS misses by $0.18 [2/4/2021 7:08 AM] |
7.87 | 1.70 (27.55%) |
6.26 | 0.09 (1.46%) |
3.80 - 17.95 | 4,693,800 | 1,604,325 | 22,804 | ||
| 04-02-2021 | PM | BCLI | Brainstorm Cell Therapeutics Inc. | 178.04 | -0.37 | -0.48 | -0.34 | BrainStorm Cell Therapeutics EPS misses by $0.18 [2/4/2021 7:08 AM] |
6.17 | 0.30 (5.11%) |
6.22 | 0.05 (0.81%) |
3.80 - 17.95 | 742,306 | 1,604,325 | 792 | ||
| 15-10-2020 | PM | 7:00 AM ET (Oct 15) |
BCLI | Brainstorm Cell Therapeutics Inc. | 529.71 | -0.14 | -0.24 | -0.25 | BrainStorm Cell Therapeutics EPS beats by $0.12 [10/15/2020 7:11 AM] |
15.33 | -1.36 (-8.15%) |
16.82 | 0.13 (0.78%) |
3.58 - 17.95 | 1,102,160 | 428,773 | 1,423 | |
|
|
||||||||||||||||||
| 05-08-2020 | PM | 6:30 AM ET (Aug 5) |
BCLI | Brainstorm Cell Therapeutics Inc. | 398.92 | -0.25 | -0.24 | -0.23 | BrainStorm Cell Therapeutics EPS beats by $0.01 [8/5/2020 7:11 AM] |
13.00 | -0.39 (-2.91%) |
13.80 | 0.41 (3.06%) |
3.43 - 17.20 | 729,641 | 761,801 | 1,801 | |
|
|
||||||||||||||||||